The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
Open accessAbstract
Background: Many adults eligible for statin therapy for cardiovascular disease prevention are untreated. Our objective was to investigate patient‐reported reasons for statin underutilization, including noninitiation, refusal, and discontinuation. Methods and Results: This study included the 5693 adults recommended for statin therapy in the PALM (Patient and Provider Assessment of Lipid Management) registry. Patient surveys evaluated statin experience, reasons for declining or discontinuing statins, and beliefs about statins and cardiovascular disease risk. Overall, 1511 of 5693 adults (26.5%) were not on treatment. Of those not on a statin, 894 (59.2%) reported never being offered a statin, 153 (10.1%) declined a statin, and 464 (30.7%) had discontinued therapy. Women (relative risk: 1.22), black adults (relative risk: 1.48), and those without insurance (relative risk: 1.38) were most likely to report never being offered a statin. Fear of side effects and perceived side effects were the most common reasons cited for declining or discontinuing a statin. Compared with statin users, those who declined or discontinued statins were less likely to believe statins are safe (70.4% of current users vs. 36.9% of those who declined and 37.4% of those who discontinued) or effective (86.3%, 67.4%, and 69.1%, respectively). Willingness to take a statin was high; 67.7% of those never offered and 59.7% of patients who discontinued a statin would consider initiating or retrying a statin. Conclusions: More than half of patients eligible for statin therapy but not on treatment reported never being offered one by their doctor. Concern about side effects was the leading reason for statin refusal or discontinuation. Many patients were willing to reconsider statin therapy if offered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In a registry that studied reasons why eligible patients were not taking a statin, 59% reported never being offered treatment, 10% declined a statin, and 31% discontinued therapy.18”
From Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients (2023) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Self-citationA Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,920
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,781
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Self-citationAdherence with statin therapy in elderly patients with and without acute coronary syndromes
Jackevicius, C. A. (2002) · JAMA · doi:10.1001/jama.288.4.462 · Cited by 1,077
Persistence of Use of Lipid-Lowering Medications
Avorn, J., Monette, J., Lacour, A. S., Bohn, R. L., Monane, M., Mogun, H., & LeLorier, J. (1998) · JAMA · doi:10.1001/jama.279.18.1458 · Cited by 635
Application of New Cholesterol Guidelines to a Population-Based Sample
Pencina, M. J., Navar‐Boggan, A. M., D’Agostino, R. B., Williams, K., Neely, B., Sniderman, A. D., & Peterson, E. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315665 · Cited by 612
Self-citationNissen, S. E., Stroes, E., Dent-Acosta, R. E., Rosenson, R. S., Lehman, S. J., Sattar, N., Preiss, D., Bruckert, E., Ceška, R., Lepor, N., et al. (2016) · JAMA · doi:10.1001/jama.2016.3608 · Cited by 522
Risks Associated With Statin Therapy: A Systematic Overview of Randomized Clinical Trials
Kashani, A., Phillips, C. O., Foody, J. M., Wang, Y., Mangalmurti, S., Ko, D. T., & Krumholz, H. M. (2006) · Circulation · doi:10.1161/circulationaha.106.624890 · Cited by 474
Cited by
Sorted by citations
Prevalence of statin intolerance: a meta-analysis
Bytyçi, I., Penson, P. E., Mikhailidis, D. P., Wong, N. D., Hernandez, A. V., Sahebkar, A., Thompson, P. D., Mazidi, M., Rysz, J., Pella, D., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac015 · Cited by 481
Nanna, M. G., Wang, T. Y., Xiang, Q., Goldberg, A. C., Robinson, J. G., Roger, V. L., Virani, S. S., Wilson, P. W. F., Louie, M. J., Koren, A., et al. (2019) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005562 · Cited by 313
Self-citationZhao, M., Woodward, M., Vaartjes, I. C. H., Millett, E. R. C., Klipstein‐Grobusch, K., Hyun, K. K., Carcel, C., & Peters, S. A. E. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014742 · Cited by 253
Managing Atherosclerotic Cardiovascular Risk in Young Adults
Stone, N. J., Smith, S. C., Orringer, C. E., Rigotti, N. A., Návar, A. M., Khan, S. S., Jones, D. W., Goldberg, R. B., Mora, S., Blaha, M. J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.016 · Cited by 255
Roeters van Lennep, J. E., Tokgözoğlu, L. S., Badimon, L., Dumanski, S. M., Gulati, M., Hess, C. N., Holven, K. B., Kavousi, M., Kayıkçıoğlu, M., Lutgens, E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad472 · Cited by 229
High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.
Nelson, A. J., Haynes, K., Shambhu, S., Eapen, Z. J., Cziraky, M. J., Nanna, M. G., Calvert, S. B., Gallagher, K., Pagidipati, N. J., & Granger, C. B. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.02.048 · Cited by 157
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
Nissen, S. E., Menon, V., Nicholls, S. J., Brennan, D., Laffin, L., Ridker, P., Ray, K. K., Mason, D., Kastelein, J. J. P., Cho, L., et al. (2023) · JAMA · doi:10.1001/jama.2023.9696 · Cited by 146
Self-citationMendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function
Rosoff, D. B., Bell, A. S., Jung, J., Wagner, J., Mavromatis, L. A., & Lohoff, F. W. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.05.041 · Cited by 126
New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B
Nurmohamed, N. S., Návar, A. M., & Kastelein, J. J. P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.079 · Cited by 116
Desai, N. R., Farbaniec, M., & Karalis, D. G. (2022) · Clinical Cardiology · doi:10.1002/clc.23935 · Cited by 93
Elder, P., Sharma, G. V., Gulati, M., & Michos, E. D. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100028 · Cited by 91
Gao, Y., Shah, L. M., Ding, J., & Martin, S. S. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028205 · Cited by 82
Underberg, J. A., Toth, P. P., & Rodríguez, F. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2117498 · Cited by 81
The Integration of Clinical Trials With the Practice of Medicine
Angus, D. C., Huang, A. J., Lewis, R. J., Abernethy, A. P., Califf, R. M., Landray, M., KASS, N. E., Bibbins-Domingo, K. B., Abbasi, A. B., Abebe, K. Z., et al. (2024) · JAMA · doi:10.1001/jama.2024.4088 · Cited by 91
Self-citationWilkinson, M. J., Lepor, N. E., & Michos, E. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028892 · Cited by 70
Parental Views of Facilitators and Barriers to Research Participation: Systematic Review
Nathe, J. M., Oskoui, T., & Weiss, E. M. (2022) · PEDIATRICS · doi:10.1542/peds.2022-058067 · Cited by 75
Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review
Claessen, B. E. P. M., Guedeney, P., Gibson, C. M., Angiolillo, D. J., Cao, D., Lepor, N. E., & Mehran, R. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018897 · Cited by 67
Návar, A. M., Kolkailah, A. A., Gupta, A., Gillard, K. K., Israel, M. K., Wang, Y., & Peterson, E. D. (2023) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.122.009787 · Cited by 65
Self-citationSud, M. K., Han, L., Koh, M., Abdel-Qadir, H. M., Austin, P. C., Farkouh, M. E., Godoy, L. C., Lawler, P. R., Udell, J. A., Wijeysundera, H. C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.033 · Cited by 64
Sarraju, A., Brennan, D. M., Hayden, K., Stronczek, A., Goldberg, A. C., Michos, E. D., McGuire, D. K., Mason, D., Tercek, G., Nicholls, S. J., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00721-4 · Cited by 64
Self-citationSharpton, S. R., & Loomba, R. S. (2023) · Hepatology · doi:10.1097/hep.0000000000000278 · Cited by 62
Swerdlow, D. I., Rider, D. A., Yavari, A., Lindholm, M., Campion, G., & Nissen, S. E. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab100 · Cited by 58
Jacobson, T. A., Cheeley, M. K., Jones, P. H., Forge, R. L., Maki, K. C., López, J. A. G., Xiang, P., Bushnell, D. M., Martin, M. L., & Cohen, J. D. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.04.011 · Cited by 57
Awad, K., Mohammed, M., Zaki, M. M., Abushouk, A. I., Lip, G. Y. H., Blaha, M. J., Lavie, C. J., Toth, P. P., Jukema, J. W., Sattar, N. A., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02009-1 · Cited by 53
Trends in Lipid, Lipoproteins, and Statin Use Among U.S. Adults
Patel, N., Bhargava, A., Kalra, R., Parcha, V., Arora, G., Muntner, P., & Arora, P. K. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.026 · Cited by 53
Adhikari, A., Tripathy, S., Chuzi, S., Peterson, J., & Stone, N. J. (2021) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2020.10.007 · Cited by 52
Brown, C. J., Chang, L., Hosomura, N., Malmasi, S., Morrison, F. J. R., Shubina, M., Lan, Z., & Turchin, A. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.1047 · Cited by 49
A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults
Osadnik, T., Goławski, M., Lewandowski, P., Morze, J., Osadnik, K., Pawlas, N., Lejawa, M., Jakubiak, G. K., Mazur, A., Schwingshackl, L., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106402 · Cited by 52
Nishikido, T. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01752-4 · Cited by 45
Rachamin, Y., Grischott, T., Rosemann, T. J., & Meyer, M. R. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.02.024 · Cited by 46
George, S. Z., Lentz, T. A., & Goertz, C. (2021) · Translational research · doi:10.1016/j.trsl.2021.04.006 · Cited by 44
Návar, A. M., Wang, T. Y., Li, S., Mi, X., Li, Z., Robinson, J. G., Virani, S. S., & Peterson, E. D. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.006548 · Cited by 43
Self-citationRuseckaite, R., Mudunna, C., Caruso, M., & Ahern, S. (2023) · Health and Quality of Life Outcomes · doi:10.1186/s12955-023-02155-5 · Cited by 42
Artificial Intelligence–Enabled Analysis of Statin-Related Topics and Sentiments on Social Media
Somani, S. S., van Buchem, M. M., Sarraju, A., Hernandez‐Boussard, T., & Rodríguez, F. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.9747 · Cited by 45
Gaps and Disparities in Primary Prevention Statin Prescription During Outpatient Care
Metser, G., Bradley, C., Moise, N., Liyanage-Don, N. A., Kronish, I. M., & Ye, S. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.08.070 · Cited by 41
Self-citationAdusumalli, S., Westover, J. E., Jacoby, D. S., Small, D. S., VanZandbergen, C., Chen, J., Cavella, A. M., Pepe, R. S., Rareshide, C. A. L., Snider, C. K., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.4730 · Cited by 41
Biologics for Reducing Cardiovascular Risk in Psoriasis Patients
Terui, H., & Asano, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031162 · Cited by 37
Statins in a Distorted Mirror of Media
Nelson, A. J., Puri, R., & Nissen, S. E. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00853-9 · Cited by 38
Barriers and Facilitators to Using Statins: A Qualitative Study With Patients and Family Physicians
Butalia, S., Lee-Krueger, R. C. W., McBrien, K. A., Leung, A. A. C., Anderson, T. J., Quan, H., Naugler, C. T., Chen, G., & Campbell, D. J. T. (2020) · CJC Open · doi:10.1016/j.cjco.2020.07.002 · Cited by 37
Clinical determinants of ischemic heart disease in Eastern Europe
Cenko, E., Manfrini, O., Fabin, N., Dorobanţu, M., Kedev, S. A., Miličić, D., Vasiljević, Z., & Bugiardini, R. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100698 · Cited by 40
Fear-Based Medical Misinformation and Disease Prevention
Návar, A. M. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1972 · Cited by 34
Sex-Specific Plaque Signature: Uniqueness of Atherosclerosis in Women
Minhas, A., Salazar, I. M. C., Kazzi, B. E., Hays, A. G., Choi, A. D., Arbab‐Zadeh, A., & Michos, E. D. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01513-3 · Cited by 33
Ahmed, S. T., Akeroyd, J. M., Mahtta, D., Street, R. L., Slagle, J. M., Návar, A. M., Stone, N. J., Ballantyne, C. M., Petersen, L. A., & Virani, S. S. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017915 · Cited by 32
Self-citationÁlvarez-Mon, M. Á., Llavero-Valero, M., Asúnsolo, Á., Zaragozá, C., Ortega, M. A., Fraile‐Μartinez, O., Quintero, J., & Álvarez‐Mon, M. (2021) · Journal of Medical Internet Research · doi:10.2196/24336 · Cited by 36
Chobufo, M. D., Regner, S. R., Zeb, I., Lacoste, J. L., Virani, S. S., & Balla, S. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac103 · Cited by 31
Self-citationCurrent challenges and future perspectives in treating patients with NAFLD-related cirrhosis
Mallet, M., Silaghi, C. A., Sultanik, P., Conti, F., Rudler, M., Ratziu, V., Thabut, D., & Pais, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000456 · Cited by 31
Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
Khoo, S., Wong, V. W., Goh, G. B., Fan, J., Chan, W., Seto, W., & Chow, W. C. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14794 · Cited by 30
Cannon, C. P., de Lemos, J. A., Rosenson, R. S., Ballantyne, C. M., Liu, Y., Yazdi, D., Elliott‐Davey, M., Mues, K. E., Bhatt, D. L., & Kosiborod, M. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.10.014 · Cited by 31
Leino, A. D., Dorsch, M. P., & Lester, C. A. (2020) · Diabetes Care · doi:10.2337/dc20-1481 · Cited by 28
Tomee, S. M., Bulder, R. M. A., Meijer, C. A., van Berkum, I., Hinnen, J.-W., Schoones, J. W., Golledge, J., Bastiaannet, E., Matsumura, J. S., Hamming, J. F., et al. (2022) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2022.11.019 · Cited by 28
Lipid-Lowering Therapy after Acute Coronary Syndrome
Pogran, E., Burger, A. L., Zweiker, D., Kaufmann, C. C., Muthspiel, M., Rega‐Kaun, G., Wenkstetten-Holub, A., Wojta, J., Drexel, H., & Huber, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13072043 · Cited by 27
Bhatt, C., Lin, E., Legere, L., Jackevicius, C. A., Ko, D. T., Lee, D. S., Schade, K., Johnston, S., Anderson, T. J., & Udell, J. A. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.030140 · Cited by 25
Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease
Wright, R. S., Ray, K. K., Landmesser, U., Koenig, W., Raal, F. J., Leiter, L. A., Conde, L. G., Han, J., & Schwartz, G. G. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.03.025 · Cited by 25
Colvin, C. L., Poudel, B., Bress, A. P., Derington, C. G., King, J. B., Wen, Y. R., Chen, L., Bittner, V., Brown, T. M., Monda, K. L., et al. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.08.001 · Cited by 25
Sarak, B., Savu, A., Kaul, P., McAlister, F. A., Welsh, R. C., Yan, A. T.-K., & Goodman, S. G. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.006646 · Cited by 25
Assessment of Antipsychotic Medications on Social Media: Machine Learning Study
Álvarez-Mon, M. Á., Donat‐Vargas, C., Santoma-Vilaclara, J., de Anta, L., Goena, J., Sánchez-Bayona, R., Mora, F., Ortega, M. A., Lahera, G., Rodríguez–Jiménez, R., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.737684 · Cited by 23
SAMSON and the Nocebo Effect: Management of Statin Intolerance
Krishnamurthy, A., Bradley, C., Ascunce, R. R., & Kim, S. M. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01729-x · Cited by 25
Self-citationPrimary nonadherence to statin medications: Survey of patient perspectives
Tarn, D. M., Pletcher, M. J., Tosqui, R., Fernández, A., Tseng, C., Moriconi, R., Bell, D. S., Barrientos, M., Turner, J. A., & Schwartz, J. B. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101357 · Cited by 24
Chi, C., Jin, W., Yew, P. Y., Lenskaia, T., Loth, M., Pradhan, P. M., Liang, Y., Kurella, P., Mehta, R., Robinson, J. G., et al. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104029 · Cited by 25
Self-citationAhmed, S. T., Mahtta, D., Rehman, H., Akeroyd, J. M., Rifai, M. A., Rodríguez, F., Jneid, H. M., Nasir, K., Samad, Z. Z., Alam, M., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.11.019 · Cited by 21
Self-citationTalic, S., Marquina, C., Zomer, E., Ofori-Asenso, R., Petrova, M., Vargas-Torres, S., Abushanab, D., Wolfe, R., Lybrand, S., Thomson, D., et al. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.101068 · Cited by 22
Trends in prevalence of guideline‐based use of lipid‐lowering therapy in a large health system
Sidebottom, A. C., Vacquier, M. C., Jensen, J. C., Bradley, S. M., Knickelbine, T., Strauss, C., & Miedema, M. D. (2020) · Clinical Cardiology · doi:10.1002/clc.23347 · Cited by 21
New and Emerging lipid-lowering Therapy
Backes, J. M., & Hilleman, D. E. (2021) · Future Cardiology · doi:10.2217/fca-2020-0217 · Cited by 21
Talukdar, J. R., Cooper, M. A., Lyutvyn, L., Zeraatkar, D., Ali, R., Berbrier, R., Janes, S., Ha, V., Darling, P. B., Xue, M., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.10.030 · Cited by 22
Learnings from Implementation Strategies to Improve Lipid Management
Lan, N. S. R., Chen, R. T., Dwivedi, G., Watts, G. F., Nicholls, S. J., & Nelson, A. J. (2025) · Current Cardiology Reports · doi:10.1007/s11886-024-02174-8 · Cited by 20
Golder, S., Weissenbacher, D., O’Connor, K., Hennessy, S., Gross, R., & Gonzalez‐Hernandez, G. (2022) · Drug Safety · doi:10.1007/s40264-022-01212-0 · Cited by 20
Nandiwada, S., Manca, D. P., Yeung, R. O., & Lau, D. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.220673 · Cited by 20
The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease
Tran, D. T., Palfrey, D., & Welsh, R. C. (2021) · PharmacoEconomics - Open · doi:10.1007/s41669-021-00257-8 · Cited by 20
A Systematic Review Uncovering Modifiable Influences on Statin Adherence
Rosenberg, J., Lampridou, S., Moores, A., Garfield, S., Wingfield, D., & Judah, G. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s502645 · Cited by 20
Thompson‐Paul, A. M., Gillespie, C., Wall, H. K., Loustalot, F. V., Sperling, L. S., & Hong, Y. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.12.005 · Cited by 19
Khoo, T., Tan, E., Limaye, V. S., Gunawardena, H., Sadler, R., Lamb, J. A., Lyu, X., Brusch, A. M., Needham, M., Austin, K., et al. (2025) · Rheumatology · doi:10.1093/rheumatology/keaf238 · Cited by 21
Bosco, G., Barbagallo, F. D. G., Marco, M. D., Miano, N., Scilletta, S., Spampinato, S., Vitale, A., Bella, F. D., Montalbano, M. E., Mauro, S. D., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1346152 · Cited by 18
Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects
Li, J., Liu, H.-H., Wu, N., Yeo, K. K., Tan, K. C. B., Ako, J., Krittayaphong, R., Tan, R., Aylward, P. E., Baek, S. H., et al. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1802426 · Cited by 19
Liu, S., McCoy, A. B., Chen, Q., & Wright, A. T. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.106104 · Cited by 17
Long-term, in vivo therapeutic effects of a single dose of miR-145 micelles for atherosclerosis
Chin, D. D., Patel, N., Lee, W., Kanaya, S., Cook, J., & Chung, E. J. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.04.001 · Cited by 19
Christiansen, C., Jeppesen, P. B., Hermansen, K., & Gregersen, S. (2023) · Nutrients · doi:10.3390/nu15245094 · Cited by 17
Ryou, I. S., Chang, J., Son, J. S., Ko, A., Choi, S., Kim, K., Kim, S. M., & Park, S. M. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045375 · Cited by 17
Setny, M., Jankowski, P., Krzykwa, A., Kamiński, K. A., Gąsior, Z., Haberka, M., Czarnecka, D., Pająk, A., Kozieł, P., Szóstak-Janiak, K., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122594 · Cited by 16
Readability and reliability of online patient education materials about statins
Ngo, S., Asirvatham, R. S., Baird, G. L., Sarraju, A., Maron, D. J., & Rodríguez, F. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100594 · Cited by 16
Technology-Assisted Self-Selection of Candidates for Nonprescription Statin Therapy
Nissen, S. E., Hutchinson, H. G., Wang, T. Y., Ballantyne, C. M., Travis, S., Morris, M., Miller, W., Hynson, J., Wolski, K., & Ridker, P. M. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.06.048 · Cited by 16
Self-citationPsoriasis and Cardiovascular Disease—An Ounce of Prevention Is Worth a Pound of Cure
Garshick, M. S., & Berger, J. S. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.4723 · Cited by 17
Factors affecting statin uptake among people living with HIV: primary care provider perspectives
Ober, A. J., Takada, S., Zajdman, D., Todd, I., Horwich, T. B., Anderson, A., Wali, S., & Ladapo, J. A. (2021) · BMC Family Practice · doi:10.1186/s12875-021-01563-0 · Cited by 15
Shah, N. P., Page, C. B., Green, C. L., Gao, M., Cavalier, J. S., McGarrah, R. W., DeWald, T. A., Sangvai, D. G., Patel, M. R., & Pagidipati, N. J. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.10.033 · Cited by 14
Romanelli, R. J., Ito, M. K., Karalis, D. G., Huang, H., Iorga, Ş. R., Kam, I. W., Thompson, S., & Azar, K. M. J. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.03.006 · Cited by 13
A Technology-Assisted Web Application for Consumer Access to a Nonprescription Statin Medication
Nissen, S. E., Hutchinson, H. G., Wolski, K., Watson, K. E., Martin, S. S., Michos, E. D., Weintraub, W. S., Morris, M., Cho, L., Laffin, L. J., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.03.388 · Cited by 13
Alqasrawi, M. N., Al-Mahayri, Z. N., Albawa’neh, A. S., Khasawneh, L. Q., Dabaghie, L., Altoum, S. M., Hamza, D., Misra, V., Ouda, H. Z., Aburuz, S., et al. (2025) · Human Genomics · doi:10.1186/s40246-025-00753-6 · Cited by 15
Návar, A. M., Electricwala, B., Multani, J. K., Zhou, Z., Chen, C., Agatep, B. C., Petrilla, A. A., Schwartz, T., N’Dri, L., Cristino, J. R., et al. (2025) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2024.12.029 · Cited by 12
Shetty, N. S., Gaonkar, M. P., Patel, N., Knowles, J. W., Natarajan, P., Arora, G., & Arora, P. K. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.09.016 · Cited by 12
Kulkarni, S., Watts, M., & Kostapanos, M. S. (2024) · BMJ · doi:10.1136/bmj-2022-072584 · Cited by 12
Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022
Slavin, S. D., Berman, A. N., Beam, A. L., Návar, A. M., & Mittleman, M. A. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032678 · Cited by 12
Weeda, E. R., Bishu, K. G., Ward, R. C., Axon, R. N., Taber, D. J., & Gebregziabher, M. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01730-8 · Cited by 12
Lim, H. M., Ng, C. J., Abdullah, A. B., Danee, M., Raubenheimer, J., & Dunn, A. G. (2024) · Digital Health · doi:10.1177/20552076241241250 · Cited by 12
Overcoming patient reluctance to statin intolerance
Katamesh, B. E., Mickow, A., Huang, L., Dougan, B. M., Ratrout, B. M., Nanda, S., & Vincent, A. (2024) · Kardiologia Polska · doi:10.33963/v.phj.100526 · Cited by 11
Geschlechterspezifische Aspekte kardiovaskulärer Erkrankungen
Baessler, A., Bauer, P., Becker, M., Berrisch-Rahmel, S., Goldmann, B. U., Grünig, E., Hamm, C., Meder, B., Kindermann, I., Ong, P., et al. (2024) · Die Kardiologie · doi:10.1007/s12181-024-00694-9 · Cited by 11
Ageeb, S. A., Abdelmoghith, A., ElGeed, H. A., Awaisu, A., ElMansor, A., & Owusu, Y. (2024) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5879 · Cited by 12
Shahid, I., Satish, P., Gullapelli, R., Nicholas, J. C., Javed, Z., Avenatti, E., Bose, B., Mahajan, S., Roy, T. L., Sharma, G. V., et al. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100722 · Cited by 13
Dyslipidemia and statin use in people with HIV-1 infection: beyond the lipid-lowering effect
Gazzaniga, G., Ridolfi, M., Lazzaro, A., Brogi, T., Pignatelli, P., Pastori, D., & Mezzaroma, I. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104110 · Cited by 10
Reasons for non-acceptance of statin therapy by patients at high cardiovascular risk
Xie, M., Martin, S. S., & Turchin, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-01930-2 · Cited by 10
What can heart failure trialists learn from oncology trialists?
Zannad, F. M., Cotter, G., Garcia, A. A., George, S., Davison, B. A., Figtree, G. A., Prasad, K., Rockhold, F. W., Schilsky, R. L., Stockbridge, N., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab236 · Cited by 10
Kayıkçıoğlu, M., Başaran, Ö., Doğan, V., Mert, K. U., Mert, G. Ö., Özdemir, İ. H., Rencüzoğulları, İ., Karadeniz, F. Ö., Tekinalp, M., Aşkın, L., et al. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.09.013 · Cited by 10
Metadata
- Authors
- Bradley, C. K., Wang, T. Y., Li, S., Robinson, J. G., Roger, V. L., Goldberg, A. C., Virani, S. S., Louie, M. J., Lee, L. V., Peterson, E. D., & Navar, A. M.
- Affiliations
- Duke University (US)
- University of Iowa (US)
- Mayo Clinic (US)
- Washington University in St. Louis (US)
- Baylor College of Medicine (US)
- Regeneron (United States) (US)
- Sanofi (United States) (US)
- Department of Medicine and Duke Clinical Research Institute Duke University School of Medicine Durham NC
- Corresponding author
- Bradley, Corey K.
- ORCID
- Venue
- Journal of the American Heart Association
- Published
- 2019-04-02
- Volume
- 8
- Issue
- 7
- Pages
- e011765-e011765
- ISSN
- 2047-9980 (ISSN-L)
- PMC
- PMC6509731
- OpenAlex
- W2923928888
- Cited by
- 286
- References
- 25
- Citations by year
- 2026: 34 · 2025: 41 · 2024: 56 · 2023: 43 · 2022: 30 · 2021: 41 · 2020: 28 · 2019: 13
- FWCI
- 26.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Journal of the American Heart Association (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- eCommons - AKU (Aga Khan University) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K01HL133416)
- Duke Clinical Research Institute
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- statin therapy, statin discontinuation, fear of side effects, cardiovascular disease prevention, lipid control, health beliefs, racial and ethnic disparities, insurance status
- MeSH terms
- Patient Reported Outcome Measures, Adult, Aged, Attitude to Health, Black or African American, Cardiovascular Diseases, Fear, Female, Humans, Male, Middle Aged, Motivation, Practice Patterns, Physicians', Primary Prevention, Registries, Sex Factors, United States, Treatment Refusal, Hydroxymethylglutaryl-CoA Reductase Inhibitors, White People, Atherosclerosis, Healthcare Disparities, Medication Adherence, Secondary Prevention, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
